新一代无导线心脏起搏器完成首批手术

Core Viewpoint - Abbott's new generation AVEIR™ DR leadless cardiac pacemaker has successfully completed its first clinical surgeries in over 20 hospitals across China, marking a significant advancement in cardiac treatment options [1] Group 1: Product and Technology - The AVEIR™ DR leadless cardiac pacemaker offers a minimally invasive implantation method, which not only shortens surgery time but also significantly enhances surgical safety, allowing patients to return to normal life more quickly [1] - The device features a compact design and is equipped with specialized delivery and retrieval catheters, enabling safe removal in case of battery depletion or changes in treatment needs [1] Group 2: Clinical Significance - The implantation of cardiac pacemakers is crucial for treating severe bradyarrhythmias, playing a vital role in saving patients' lives and restoring their health [1] - The technology represents a leap from traditional to advanced cardiac pacing, embodying a patient-centered approach to precision medicine [1]